chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was tired the night of the shot and my arm was painful near the injection site, hard to move arm and touch caused great pain. My neck also started to lock up from my shoulder across to my spine and up my neck. This lasted about three days with occasional tension in the neck area coming back. Next morning I was very achy and my entire body felt like my muscles had a buildup of lactic acid. I did not have a fever but felt feverish that night. I felt the fever broke Saturday night/early Sunday morning (4/4) while I was asleep. I developed a slight cough for a few days and the muscle aches decreased by half each day. I felt mostly better after a week but occasionally felt tired and the cough lasted about a week. My arm developed a bolus at the injection site in the muscle that took about two weeks to go away, with occasional ice. The arm pain only lasted about 4 days before full range of motion was restored.
Syncopal episode, pallor, shaking.  Lasted for approx. 10 min. Juice and crackers given. Recovered well. Left with Mom in good condition.
Can't move left arm because of the pain; Trouble moving her left arm yesterday; Tingling in the left arm from left shoulder to left hand; Sharp pain in the left shoulder that radiated to left elbow; A spontaneous report was received from a consumer concerning a 23-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced multiple events of tingling in the left arm from left shoulder to left hand, sharp pain in the left shoulder that radiated to left elbow, trouble moving her left arm, can't move left arm because of pain.   The patient's medical history included connective tissue disorder. Concomitant medications included Montelukast, hydroxychloroquine, fexofenadine and vitamins.   On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot# 025J20-2A). On that same day, the patient experienced tingling in the left arm from left shoulder to left hand and sharp pain in the left shoulder that radiated to left elbow. The treatment information reported included aleve.   On 30 Dec 2020, the patient experienced trouble moving her left arm. The treatment information reported included aleve.  On 31 Dec 2020, the patient experienced can't move left arm because of pain. The treatment information reported included aleve.  The action taken with mRNA-1273 in response to the events was unknown.  The outcomes of the events, tingling in the left arm from left shoulder to left hand, sharp pain in the left shoulder that radiated to left elbow, trouble moving her left arm, can't move left arm because of pain, were considered unknown.; Reporter's Comments: This case concerns a 23-year-old female with nonserious events of unexpected injection site movement impairment, paraesthesia, pain in extremity, and expected arthralgia.  Event onset the same day as the first dose of mRNA-1273. Treatment with Aleve. Event outcomes unknown. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Received SPV left arm 3/15/10 (previous SPV 1990). On 3/31/10 noted red, itchy papular rash in his right wrist and forearm (pt is right handed). The rash progressed to his left wrist/forearm on 4/1/10 and on 4/2/10 to the dorsal aspect of his right foot. On 4/3/10 the pt noted the rash on his abdomen and chest. Rash worsened after a warm shower. Denied fever, chills, N, V, diarrhea, abdominal pain or sore throat. Pt had been in a hotel since 3/28/10 and was using a number of new products (soap, shampoo, detergent). On 4/5/10 the pt began taking a non sedating antihistamine. On 4/9/10 the rash was almost resolved with a small patch remaining on the right wrist and the abdomen. Additionally on 4/1/10 the pt noted right am pain (4/10, dull, constant, increase with movement); denied numbness, tingling, axillary pain or lymphadenopathy. Pt started MOTRIN 800mg bid on 4/5/10 and increased to tid with food on 4/6/10 with resolution of pain on 4/8/10 (pt has had no further NSAIDS since 4/8/10).
some leaked out but most went into her arm; some leaked out but most went into her arm; some leaked out but most went into her arm; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INCORRECT DOSE ADMINISTERED BY PRODUCT (non-serious), DEVICE LEAKAGE (non-serious), VACCINATION SITE EXTRAVASATION (non-serious), outcome "unknown" and all described as "some leaked out but most went into her arm".  The reporter considered "some leaked out but most went into her arm" associated to pneumococcal 20-val conj vac (dipht CRM197 protein).  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
Patient states after 12 hours of administration the patient was crying with painful lymph nodes, difficulty breathing, pain down left arm. The patient contacted urgent care and they had her come in to rule out hear concern. Patient states has been 3 weeks since shot and still has pain in lymph nodes and shortness of breath. The patient also states pain in left knee and has had diarrhea.
During the last two years my health has gone through a sharp decline without any expected reasons (I eat healthy food and I do continue to exercise regularly). My Presyncope symptoms started in 2020, once every other week, then, and it got worse in 2021 when I had Vasovagal Syncope, passing out while standing at the supermarket once or twice a month, causing me to hit my head on the floor every time, making me very insecure and anxious of doing anything that require me to stand. On Sept 2nd 2021, I've got an Implanted Loop Recorder that also recorded heart beat pauses during some of the Syncopes and a cardiac arrest of 25 secs while sleeping. On Nov 1st 2021, I've got a leadless pacemaker for Sick Sinus Disfunction.Since then, my life has completely changed and I am very insecure and anxious of doing anything that requires me to stand. At work I'm always scared about passing out in front of an audience while I do presentation, and when I attend  events.
This spontaneous report as received from a medical assistant refers to a 15-year-old patient of unknown gender. No information about the patient's medical history and concurrent conditions were reported. On 13-JAN-2016, the patient was vaccinated with an improperly stored dose of GARDASIL lot # K008931, expiry date 04-MAR-2017, injected in the left arm (dose and route of administration were not reported). NO concomitant therapies were reported. The administered dose was exposed to the following conditions: temperature of 33 Fahrenheit degrees for 15 hours and 15 minutes. There was no previous temperature excursion. It was not the case of a "data logger". No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all required correspondence was received.
This spontaneous report was received from a physician and from a support services director via company representatives and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 25-FEB-2016, the patient was vaccinated with a dose of an improperly stored GARDASIL 9 (strength: 0.5 ml) lot # L014198 and expiration date: 05-SEP-2017 (dose, anatomical location and route of administration were not reported). No adverse effects were reported). The dose of the vaccine was exposed to a temperature excursion (date unspecified): lasting for 120 hours, with the highest recorded temperature of 53 degrees Fahrenheit (11.66 degrees Celsius). The vaccine was stored in a refrigerator. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Pt came with Swollen right arm,  rash, and fever. Treatment included: tylenol, Benadryl QHS, and cold compressions.
have shingles,  had a vaccination and got it anyway/ suspected vaccination failure; Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 21-Jun-2022. Reporter's Comments: The patient self-reported the case via interactive digital media and described the occurrence of suspected vaccination failure. It was reported that patient had vaccination still patient had shingles at the time of reporting. The follow up would not be possible as contact details were not provided. Additional supportive information: This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation for herpes zoster were unknown.
Mom noticed swelling to (R) thigh in the evening? Brought un to see dr 12-3-14. (R) thigh with swelling 3x2x2 inches. 12-3-14 (Tx) pt was given KEFLEX 250mg/5ml = 2 1/2 mls po tid x 10 days.
pt vomited 3 hrs p/vax; mom called clinic & was advised to call MD; mom also stated that pt was pale & limp & denied fever; pt saw hlth professional who stated had Bilat ear infect; sx due to ear infect, virus, & shots; t100 ax; tx ATB
IM influenza vaccine was mistaken for 'FluMist' and administered to the nasal passage as a liquid. Once mistake was determined, it was given IM.
A week after receiving my first dose of the Covid vaccination, I experienced localized pain in same location of vaccination. Arm has localized mild pain, itching and a welt or large hive.
sore throat; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old-non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via unspecified route of administration on 23Mar2021 at 09:30 (at the age of 50-years-old) as a single dose for COVID -19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 05:00, the patient experienced sore throat. it was reported that the patient got her shot 2 weeks ago and still had a sore throat and it was not getting any better. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of sore throat was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Hiccups; Sick after covid booster shot; This spontaneous case was reported by a consumer and describes the occurrence of HICCUPS (Hiccups) and ILLNESS (Sick after covid booster shot) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced HICCUPS (Hiccups) and ILLNESS (Sick after covid booster shot). At the time of the report, HICCUPS (Hiccups) had not resolved and ILLNESS (Sick after covid booster shot) outcome was unknown.            It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Concomitant medications were not reported.  No treatment information was provided by the reporter. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
On 1-721 at approximately 8pm. patient started with itching to the (L) deltoid. Patient then noticed that (L) deltoid injection site was red & swollen. Patient works in PCP office & was evaluated by PCP. Prescribed prednisone taper, Atarax, & betamethasone cream on 1-8-21. Still with redness/swelling.
After 3 days I had tingling on my toes and fingers, headaches, food taste blend for 3 weeks.  Tingling on toes better but increasing tingling and numbness on right pinky, ring finger and middle fingers  and a little bit on the thumb and along the side of the back of the arm from the shoulder.  Also have tingling along the right side on the right leg.   I feel tired a lot.  My numbness and tingling gotten worsen following the month of July.   I thought it was going to go away but as time goes by it getting worsen.  The back of my neck also feel pain.
This spontaneous report was received from a licensed practical nurse an refers to 6 patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # M018625, expiration date: 11-AUG-2018 (exact dose and route of administration were not reported). There was no adverse effect reported. The administered doses experienced the temperature excursion between 46 degrees Fahrenheit (F)  and 77 F for 6 hours. A data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.  Additional information has been requested.; Sender's Comments:  US-009507513-1701USA009338: US-009507513-1701USA007030: US-009507513-1701USA009337:
due to ulcerative colitis, appears to have triggered inflammation in bowel; due to ulcerative colitis, appears to have triggered inflammation in bowel; severe stomach intestinal cramping; Extreme lower back pain; This is a spontaneous report from a non-contactable consumer (patient). A 55-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm, on 30Mar2021 at 13:45 for COVID-19 immunisation.  Medical history included ulcerative colitis. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 04Mar2021 (at the age of 55-years-old), in the left arm, for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced due to ulcerative colitis, appears to have triggered inflammation in bowel, extreme lower back pain, and severe stomach intestinal cramping on 01Apr2021. The clinical course was reported as follows: The patient experienced extreme lower back pain approximately within 40 hours after vaccination. Also, severe stomach intestinal cramping occurred. Due to the ulcerative colitis, it appears to have triggered inflammation in the bowel. The clinical outcome of ulcerative colitis, appears to have triggered inflammation in bowel, extreme lower back pain, and severe stomach intestinal cramping was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Tightness in chest.  Pain and soreness in arm.   Swelling started evening of the injection and continued throughout the weekend when I went to the hospital.    In 48 hours the injection site was painful, red, hot to the touch  and very swollen.   Two trips to ER on 4/7 being treated for allergic reaction.  On 4/8 went to doctor and was ad used to go to ER for testing.   Was admitted for cellulitis and severe infection and hospitalization until 3/10.   Subsequent return to ER 3 days later for follow up because of swelling and elevated white blood cell count, elevated blood work suggesting blood clots.
Pt called PCHC as this was given in her home as she was homebound.  A couple hours after COVID vaccine she began having severe itching and feeling uncomfortable.   Did not have any type of respiratory distress.
Patient was pre-screened for vaccine eligibility and determined to be eligible, however, was placed in the 30 minute observation group due to history of severe allergic reactions. Once the 30 minutes was up, patient left clinic and got into her car. She noticed redness/rash/possible hives forming on her face, neck, upper neck and upper arms when she got in her car. Patient returned to clinic and notified staff she thought she may be having an allergic reaction. Medical personnel examined her and decided to call 911 for additional resources and a more thorough assessment. Patient stated she felt like her chest was tight and was visibly upset. Once clinic staff informed her the ambulance was on the way, patient stated she thought chest tightness may be related to anxiety about what was happening. She said this looked similar to other allergic reactions she had that developed into something more serious. Patient used both of her inhalers. Ambulance arrived and did an assessment and concluded patient was having an allergic reaction, however, her oxygen saturation was 100% and patient was talking normally so Paramedic did not believe her breathing was compromised. Rash/redness remained localized to areas described above. Patient lived about an hour from the clinic site and was informed closest hospital was 45 minutes away with intermittent periods of no cell service, medical staff recommended ambulance transport. Patient really did not want to go by ambulance because she stated she "felt ok" but acknowledged the risk of driving herself that far of a distance and possibly not being able to call for help - she did agree to go by ambulance. Patient was transported without incident in approximately 15 minutes of the ambulance arriving.
tested positive for covid after 1st dose received on 03Jan2021; tested positive for covid after 1st dose received on 03Jan2021; This is a spontaneous report from a contactable Nurse via a Pfizer-sponsored program named Pfizer First Connect. This nurse reported similar events for 15 residents and 5 staff members. This case was for the 10th of 15 residents.   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 03Jan2021 at the first single dose for covid-19 immunization. The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient experienced tested positive for covid in Jan2021 after 1st dose received. The outcome of events was unknown.   Information about batch/lot number has been requested.; Sender's Comments: A causal association between reported event and suspect BNT162B2 cannot be excluded.,Linked Report(s) : US-PFIZER INC-2021028829 same reporter, same drug/event, different patient
Since getting the last vaccine I have been getting a random rash as follows:  April 28,2021 -11AM -  slight rash on arms, elbow and face. It went away within 20-30 mins.  May 8,2021 - 11 AM -  bright red rash all over face, neck, chest, arms, and hands. It was hot and itchy. It appeared and covered all the areas within about 1 minute.  I took Benedryl and it went away within the next hour  May 17, 2021 - 11:30 AM - Same as the previous  May 24, 2021 - 10:30 AM - Same as previous but it felt like it was harder to breath, like my chest was tighter. I was still able to breath easy.  May 25, 2021 - talked to my dr and she prescribed Ivermectin and several more supplements to take for 2 months. (Bamboo, XenoProtx, Zinc, Vein Lite, Silvercillin)  June 2, 2021 - 10 AM - slight redness and rash on elbows but went away quickly.  June 9, 2021 - 12PM - same as previous  July 30, 2021 - 7PM - For the 2 months I was taking the supplements and Ivermectin the rash has not really came back. On this date I had gone the 2 months and had stopped taking  the Ivermectin for a week prior and vitamins for 3 days prior. Again, All at once, and within 1-2 mins I got hot and red and itchy. This time it was worse - face, neck, chest, arms, hands, and this time all over legs and feet as well. took Benedryl and it went away.  Spoke to dr and went back on everything.
This spontaneous report as received from physician, via a company representative, refers to a male patient of unknown age. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with his first dose of GARDASIL, 0.5 ml, intramuscular (lot number and expiration date were not provided). No concomitant therapies were reported. According to the physician, the patient "felt faint" (dizziness) after being vaccinated with his first dose of GARDASIL, but felt fine after his second and third doses. The patient did not receive any treatment for his adverse event, however he went to the doctor for medical attention. The outcome of dizziness was reported as recovered on an unspecified date. The reporter did not provide a causality assessment for the event. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age or gender. No information was provided regarding the patient's concomitant medications, pertinent medical history, drug reactions or allergies. On an unspecified date in approximately 2013 (reported as "about 5 years ago"), the patient was vaccinated with a dose of ZOSTAVAX subcutaneously (exact dose, lot# and expiration date were not reported) for prophylaxis. On 20-JAN-2018, the patient was vaccinated with the second dose of ZOSTAVAX subcutaneously (exact dose, lot# and expiration date were not reported). No adverse effects were reported. No product quality complaint (PQC) was involved.
Hives and swelling on the cheek and arm as well on the thigh of the injection site.
Extremely swollen, hard and painful lymph nodes in left arm, left pectoral, under left clavicle/first rib; extremely swollen tongue and gums; hives across left shoulder, neck, chest and abdomen - all persisted for 5 days